Author： Corruble E. Benyamina A. Bayle F. Falissard B. Hardy P.
Publisher： Elsevier
ISSN： 0278-5846
Source： Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol.27, Iss.5, 2003-08, pp. : 829-833
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is severe depression a separate indication?
By Montgomery S.A. Lecrubier Y.
European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. :
Access to resources
Recommend
Mirtazapine, fluoxetine comparable for severe depression
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :
Venlafaxine ER switch beneficial in severe depression
Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. :
Long-term escitalopram beats paroxetine for severe depression
Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. :
Severe Depression: Is There a Best Approach?
CNS Drugs, Vol. 15, Iss. 10, 2001-01 ,pp. :